FDA Coronavirus (COVID-19) Update: July 25th, 2020

Silver Spring, MD – The U.S. Food and Drug Administration (FDA) announced the following actions taken in its ongoing response effort to the COVID-19 Coronavirus pandemic Friday, July 24th, 2020.

The U.S. Food and Drug Administration issued an updated FDA COVID-19 Coronavirus Response At-A-Glance Summary that provides a quick look at facts, figures, and highlights of the agency’s response efforts.

FDA maintains up-to-date webpages on COVID-19-related resources including its searchable database of medical devices that have been issued emergency use authorizations during the pandemic.

Testing updates:

To date, the FDA has currently authorized 188 tests under EUAs; these include 155 molecular tests, 31 antibody tests, and 2 antigen tests.

About the U.S. Food and Drug Administration

The U.S. Food and Drug Administration (FDA), an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.